Guideline for Diagnosis and Management of Serotonin Syndrome versus Pheochromocytoma in Patients Receiving Quetiapine and Mirtazapine

Clinical Presentation

• Serotonin syndrome is far more likely than pheochromocytoma in a patient on quetiapine + mirtazapine who develops sudden autonomic changes (e.g., tachycardia, hypertension, diaphoresis)【1】【2】.
• Hyperreflexia and inducible clonus (especially in the lower extremities) are highly specific for serotonin syndrome and are virtually never seen in pheochromocytoma【1】【2】.
• Myoclonus occurs in approximately 57 % of serotonin‑syndrome cases【1】.
• Tremor accompanied by hyperreflexia is characteristic of serotonin syndrome【1】【2】.
• Muscle rigidity predominates in the lower extremities (distinct from the “lead‑pipe” rigidity of neuroleptic malignant syndrome)【3】【1】.
• Autonomic signs of serotonin syndrome include tachycardia, hypertension (which may progress to hypotension), diaphoresis, and hyperthermia usually ≤ 41.1 °C【3】【1】.
• Mydriasis (dilated pupils) is a frequent finding in serotonin syndrome【3】【1】.
• Sialorrhea (excessive salivation) and hyperactive bowel sounds with diarrhea are common autonomic manifestations【3】【1】.
• Mental‑status changes such as agitation, delirium, confusion, and anxiety are typical【4】【1】.

• Symptoms generally appear within 6–24 hours after initiating, increasing the dose of, or combining serotonergic agents【3】【1】.

• Pheochromocytoma typically lacks hyperreflexia and clonus; muscle tone and reflexes remain normal【1】【2】.
• Hypertension in pheochromocytoma is paroxysmal or sustained and evolves over weeks‑months rather than hours【5】【6】.
• Pupils are normal (no mydriasis) and bowel sounds are normal or hypoactive【1】.

Diagnostic Criteria

• Hunter Serotonin Toxicity Criteria require recent exposure to a serotonergic agent plus one of the following: spontaneous clonus; inducible clonus with agitation or diaphoresis; ocular clonus with agitation or diaphoresis; tremor with hyperreflexia; or hypertonia with temperature > 38 °C plus ocular or inducible clonus【1】【2】.
• The Hunter criteria demonstrate 84 % sensitivity and 97 % specificity for serotonin syndrome【2】.

Laboratory Evaluation

• No specific laboratory test confirms serotonin syndrome; routine labs (CBC, electrolytes, renal function, CK, liver enzymes, arterial blood gas) are obtained to assess severity and complications such as rhabdomyolysis【1】【2】.
• Elevated plasma or 24‑hour urinary metanephrines is the gold‑standard biochemical test for pheochromocytoma【8】.

Immediate Management of Serotonin Syndrome

• Immediately discontinue all serotonergic medications, including quetiapine and mirtazapine【1】【2】.
• Administer benzodiazepines (e.g., lorazepam or diazepam) as first‑line therapy for agitation and tremor【1】【2】.
• Provide intravenous fluids to counteract autonomic instability【1】【2】.
• Apply external cooling measures for hyperthermia; antipyretics are ineffective because fever is due to muscle hyperactivity【3】【1】.
• Avoid physical restraints, which can worsen muscle rigidity, hyperthermia, and lactic acidosis【1】【2】.
• For moderate‑to‑severe cases, give cyproheptadine (5‑HT₂A antagonist): 12 mg loading dose, then 2 mg every 2 h as needed, with maintenance 8 mg every 6 h orally or via NG tube; pediatric dosing ≈ 0.25 mg/kg/day【3】【1】.
• Chlorpromazine may be used as an alternative serotonergic antagonist, but cyproheptadine is preferred【3】.
• If temperature exceeds 41.1 °C, initiate rapid sequence sedation, non‑depolarizing neuromuscular blockade (e.g., vecuronium or rocuronium), and endotracheal intubation【3】【1】.
• Approximately 25 % of severe cases require ICU admission for mechanical ventilation【1】【2】.

Prognosis

• Mild‑to‑moderate serotonin syndrome usually resolves within 24–48 hours with supportive care【1】.
• Severe cases carry an estimated mortality of ~11 %【1】【2】.

Management of Pheochromocytoma (If Ultimately Diagnosed)

• Begin alpha‑adrenergic blockade (phenoxybenzamine 10–20 mg 2–3 times daily, prazosin 1–3 mg 2–3 times daily, or doxazosin 2–4 mg 2–3 times daily) for 10–14 days before any other therapy【5】【6】.
• Beta‑blockers must not be introduced before adequate alpha‑blockade to avoid unopposed alpha‑stimulation and hypertensive crisis【5】【6】.
• Intravenous phentolamine is indicated for acute hypertensive crises【5】【6】.
• Definitive treatment is surgical resection, preferably laparoscopic adrenalectomy【5】【6】【9】.

Critical Pitfalls

• Do not postpone treatment while awaiting laboratory confirmation; serotonin syndrome is a clinical diagnosis requiring prompt intervention【1】【2】.
• Distinguish serotonin syndrome from neuroleptic malignant syndrome (NMS): NMS develops over days, shows “lead‑pipe” rigidity, bradyreflexia, and normal pupils, whereas serotonin syndrome appears within hours with hyperreflexia and clonus【3】【1】【2】.
• Avoid adrenal biopsy in the acute setting, as it can precipitate a hypertensive crisis in unsuspected pheochromocytoma【8】.